The Critical Vector · Clinical Reasoning — Verified

Hemorrhagic Shock: Not Killing Your Patient With Salt Water

HR 140. BP 70/palp. Cold. Bleeding. You reach for the NS bag. Stop. Put the crystalloid down.

Original post: definshock. This page is an independent third-party verification, not affiliated with or endorsed by the account.

Verdict: "put the crystalloid down" is exactly right, and it's backed by two decades of trauma resuscitation evidence — large-volume crystalloid in hemorrhagic shock is now understood to actively worsen outcomes through dilutional coagulopathy, not just to be a suboptimal filler compared to blood.

Why Crystalloid Specifically Hurts Here

Mechanism	Effect
Dilutional coagulopathy	Crystalloid dilutes circulating clotting factors and platelets, directly worsening the patient's ability to form clot at the bleeding source — making the hemorrhage itself harder to control
Clot disruption from pressure normalization	Aggressively restoring blood pressure before hemostasis is achieved can dislodge early, fragile clot at the injury site ("popping the clot"), restarting bleeding that had begun to tamponade
Hypothermia	Room-temperature crystalloid given in volume directly contributes to hypothermia, one leg of the trauma "lethal triad" alongside acidosis and coagulopathy — each of which worsens the others
No oxygen-carrying capacity	Unlike blood products, crystalloid does nothing to restore the oxygen-delivery capacity that hemorrhage is actively destroying

The Evidence Base

This is a settled, guideline-level shift in trauma resuscitation

Damage control resuscitation — permissive hypotension, minimizing crystalloid, and early balanced blood product transfusion in a 1:1:1 ratio (plasma:platelets:RBCs) — replaced large-volume crystalloid resuscitation specifically because trials and registry data (PROPPR and its predecessors) showed better outcomes with blood-product-forward strategies. Current ATLS and military/civilian trauma guidelines reflect this directly: minimize crystalloid in active hemorrhage, target permissive hypotension (SBP ~80–90 mmHg, or a palpable radial pulse) until hemorrhage source control is achieved, and move to blood products as early as possible — whole blood or balanced component therapy, not saline, as the primary resuscitation fluid.

What to Reach for Instead

Permissive hypotension until definitive hemorrhage control (surgery, angioembolization, or the bleeding source is otherwise addressed) — not normalizing blood pressure as the immediate goal.
Blood products early, ideally whole blood where available, or balanced 1:1:1 component ratio — treating the actual deficit (oxygen-carrying capacity and clotting factors), not just intravascular volume.
TXA within 3 hours of injury where indicated, per CRASH-2 and CRASH-3 data, as an adjunct antifibrinolytic.
Minimize crystalloid to the smallest volume needed to bridge to blood products — not as the default resuscitation fluid.
Source control as the actual treatment: no resuscitation strategy substitutes for stopping the bleeding.

Bottom Line

The source post's instinct is exactly right and reflects the current standard of care: in hemorrhagic shock, large-volume crystalloid isn't a neutral bridge to blood products, it actively worsens outcomes through dilutional coagulopathy, clot disruption, and hypothermia. The modern approach is permissive hypotension, minimal crystalloid, early balanced blood products, and rapid source control — "save this before the pager goes off" is the right framing for a decision that has to happen fast and by reflex.

Sources

definshock. Original Instagram post, "Hemorrhagic Shock: An Intensivist's Guide to Not Killing Your Patient With Salt Water." — read the original post before relying on this summary.
Holcomb JB, Tilley BC, Baraniuk S, et al; PROPPR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma. JAMA. 2015;313(5):471–482.
CRASH-2 collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage. Lancet. 2010;376(9734):23–32.
American College of Surgeons. Advanced Trauma Life Support (ATLS), 10th ed. — damage control resuscitation principles.
Cannon JW. Hemorrhagic Shock. N Engl J Med. 2018;378(4):370–379.